IOVA - Iovance Biotherapeutics Director Makes $55K Stock Purchase | Benzinga
Merrill A McPeak, Director at Iovance Biotherapeutics (NASDAQ:IOVA), reported a large insider buy on September 19, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that McPeak purchased 10,000 shares of Iovance Biotherapeutics. The total transaction amounted to $55,599.
Iovance Biotherapeutics shares are trading up 2.49% at $5.57 at the time of this writing on Wednesday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Important
Insider transactions shouldn't be used primarily to ...